Related Experiment Video

Updated: Apr 25, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

9.4K

Plasminogen activator inhibitor-1 in aging

Koji Yamamoto1, Kyosuke Takeshita2, Hidehiko Saito3

  • 1Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.

Seminars in Thrombosis and Hemostasis
|August 15, 2014
PubMed

Insights

Plasminogen activator inhibitor-1 (PAI-1) is elevated in aging and associated diseases. This review highlights PAI-1

Area of Science:

  • Biomedical Science
  • Pathophysiology
  • Aging Research

Background:

  • Plasminogen activator inhibitor-1 (PAI-1) is a key inhibitor of fibrinolysis.
  • PAI-1 levels increase in thrombotic, fibrotic, and cardiovascular diseases, common in older adults.
  • Elevated PAI-1 is linked to aging pathologies like infarction, atherosclerosis, fibrosis, and metabolic syndromes.

Purpose of the Study:

  • To review the role of PAI-1 in the pathophysiology of aging.
  • To highlight PAI-1's contribution to aging-associated disorders.
  • To discuss PAI-1 as a marker of senescence and the senescence-messaging secretome.

Main Methods:

  • Literature review of studies on PAI-1 and aging.
  • Analysis of PAI-1's function in fibrinolysis and extracellular matrix degradation.
  • Examination of PAI-1 expression in aged individuals and related diseases.

Main Results:

  • PAI-1 expression is significantly upregulated in aged individuals.
  • PAI-1 is implicated in various aging-associated pathologies, including cardiovascular events and fibrosis.
  • PAI-1 is recognized as a marker of cellular senescence.

Conclusions:

  • PAI-1 plays a critical role in the development of aging-associated pathological changes.
  • Understanding PAI-1's role is crucial for addressing age-related diseases.
  • PAI-1 is a significant factor in the aging process and associated health conditions.

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

165
Author Spotlight: Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus06:45

Author Spotlight: Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

Published on: June 2, 2023

2.4K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
377
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
365
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
849
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
350